IGF2BP3 and chronic obstructive pulmonary disease: CONCLUSION: This study confirmed that METTL3/IGF2BP3 enhanced the stability of LCN2 and hindered the NRF2/SLC7A11/GPX4 pathway through m6A methylation modification, thereby aggravating the progression of COPD.